ArticleToxicology reports2026
Integrated biomarker analysis of multi-organ effects following MDMA and alcohol co-consumption in Pakistan: A pilot study.
Article in Toxicology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
3,4-Methylenedioxymethamphetamine (MDMA, "Ecstasy") is a widely abused recreational drug associated with multi-organ toxicity. Objective was to compare hepatic, renal, and systemic biochemical abnormalities after acute MDMA exposure alone and with alcohol. This cross-sectional pilot study was conducted at Sheikh Zayed bin Al Nahyan and Shalamar Medical and Dental Colleges, Pakistan. The study included 24 exposed participants (ecstasy-only n = 10; ecstasy and alcohol n = 14) and 20 controls. Blood samples were analyzed for AST (<37 U/L), ALT (<63 U/L), ALP (46-116 U/L), GGT (<55 U/L), LDH (81-234 U/L), Urea (10-50 mg/dl), Creatinine (0.7-1.4 mg/dL), Uric Acid (3.5-7.2 mg/dl), and CK (39-232 U/L). Marked hepatorenal biochemical injury was predefined as ALP > 3 times the laboratory specific upper limit of normal or serum urea > 150 mg/dl. Group comparison, age and sex adjusted multivariable linear regression and ROC analyses were performed. The study group exhibited significantly elevated hepatorenal biomarkers vs. controls. Median AST, ALT and ALP were117.0, 117.5 and 439.0 U/L, equivalent to 3.16, 1.86 and 3.78 x ULN, respectively. Median urea and creatinine levels were 172.5 mg/dL and 1.42 mg/dL respectively. No significant difference was found between ecstasy-only and ecstasy and alcohol after correction. Adjusted models showed significantly higher ALP, urea, and creatinine in both study groups versus controls. RSI and STI showed high apparent discrimination (AUC 1.000 and 0.890, respectively). Acute MDMA exposure was associated with marked hepatic and renal biochemical abnormalities. Alcohol co-consumption did not independently exacerbate organ damage. The RSI and STI are novel, cost-effective, and highly accurate tools for emergency triage using routine laboratory parameters.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.